Category Archives: Biotech

SpayVac

SpayVac Scales Up Production Capacity

SpayVac for Wildlife, Inc., in partnership with BioVaxys Technology Corp., has expanded production capacity at its Madison facility to support global demand for its fertility-control vaccines for animals, the company…

Cellectar Biosciences logo

Cellectar, NorthStar Announce Agreement

Cellectar Biosciences and NorthStar Medical Radioisotopes have signed a strategic supply agreement for the procurement of NorthStar’s non-carrier added (n.c.a.) Ac-225, the company announced today. “We plan to advance CLR…

Exact Sciences logo

Exact Sciences Presents New Data on MCED Test

Exact Sciences will be sharing results for its multi-cancer early detection (MCED) test at the American Association for Cancer Research (AACR) Special Conference taking place Nov. 13-16 in San Diego,…

Cellectar Biosciences logo

Cellectar, SpectronRx to Partner

Cellectar Biosciences and SpectronRx, a radiopharmaceutical contract developer and manufacturer, have signed a commercial supply agreement for the manufacture of Cellectar’s first-in-class cancer therapy, iopofosine I 131, the company announced…

Voximetry

Voximetry Receives MDSAP Certification

Voximetry has received a Medical Device Single Audit Program (MDSAP) Certificate, bringing the company one step closer to market clearance for clinical use of its Torch Dose Assessment software in…

BioForward logo

2023 Report Shows Biohealth Impact in WI

In 2023, the biohealth industry in Wisconsin contributed $22 billion in economic output and $37.7 billion in total economic impact in the state, combining direct, indirect and induced sources, according…

SHINE Medical Technologies logo

SHINE Collaborates With UW, WARF on Treatments

SHINE Technologies and WARF Therapeutics today announced pre-clinical research results from collaborative efforts with the Advanced Radiotheranostics Lab at the University of Wisconsin. According to a release, the studies showed…

Exact Sciences logo

Exact Sciences Earns FDA Approval for Cologuard Plus

Exact Sciences announced today that the U.S. Food and Drug Administration (FDA) approved its next-generation multitarget stool DNA test called Cologuard Plus. “Cologuard Plus sets a new performance standard in…

Voximetry

Voximetry Receives $2M NIH Grant

Voximetry received a $2 million grant from the U.S. Cancer Institute, part of the National Institutes of Health, to enhance the efficiency and accuracy of conventional nuclear medicine SPECT/CT imaging,…

SHINE Medical Technologies logo

SHINE Receives 2nd DOE Grant

SHINE Technologies was awarded another Department of Energy’s Small Business Innovation Research Grant to help transform DOE-supported science and technology breakthroughs into viable products and services, creating a bridge between…